Mark Bamforth - Profile and Investment Details

Investor Profile

Mark Bamforth is a Private Equity Firm based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Blackstone Technology Group, Detector Technology, Dynex Technologies, New England Peptide, LightPointe, Adaptas Solutions, MedPharm, Avid Bioservices, CoreLab Partners, CRI Lifetree, N2 Biomedical LLC, Agilux Laboratories, Silicon Wave, ALPCO Diagnostics, ProGene Biomedical, Cequent Pharmaceuticals, CONTINUUS Pharmaceuticals, ACLARA BioSciences, TriPath Imaging, FirstRain, Ampersand Capital Partners, Proficiency, VibalogicsPNEUMAGEN LIMITED, Brammer Bio, Corpus Medical, GeneWerk, Bioventus, Magritek Ltd, Chantest, LakePharma, Magellan Diagnostics, Innovative Food Processors, Signature Genomic Laboratories, Endeca, Inceptor Bio, Viracor-IBT Laboratories, Panacos Pharmaceuticals, vivitide, Confluent Medical Technologies, Viadux, Talecris Biotherapeutics, RadPharm, Canopy Biosciences, Nitinol Devices & Components, Azurity Pharmaceuticals, Sanova Dermatology, Ensemble Communications, BioClinica, MedVenture Technology, Ortho Organizers, Kincell Bio, Nexelis, Interpace Diagnostics, Assay Designs, NutraMed, Roadrunner Pharmacy, Avista Pharma, Blue Sky Biotech, Alcami, Medifacts International, Elite One Source Nutritional Services, Genome Diagnostics (GenDx), MassBio, GENEWIZ, Kinvard Bio, Arranta Bio, Stereotaxis, Bako Diagnostics, EnteroBiotix, ETE Medical Inc, StageBio, Cyclis Pharmaceuticals, Nexcelom Bioscience, Genoptix, . Over time, Mark Bamforth has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Mark Bamforth is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Telecommunications, Genetics, Databases, Wellness, Women Founded, Enterprise Software, Consumer Goods, Antibiotics, Life Science, Engineering, Information Services, Information Technology (IT), Software, Manufacturing, Biotechnology, Genomics, Research, Consumer Software, Agriculture, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Mark Bamforth, as their portfolio suggests a familiarity and interest in this area.

Understanding Mark Bamforth’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.